Details for New Drug Application (NDA): 061718
✉ Email this page to a colleague
NDA 061718 describes KOROSTATIN, which is a drug marketed by Holland Rantos and is included in one NDA. Additional details are available on the KOROSTATIN profile page.
The generic ingredient in KOROSTATIN is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
The generic ingredient in KOROSTATIN is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 061718
| Tradename: | KOROSTATIN |
| Applicant: | Holland Rantos |
| Ingredient: | nystatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061718
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;VAGINAL | Strength | 100,000 UNITS | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
